Search

everythinglearnresearchcommunity

for

Search:↓

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Deleting the CDSN gene causes severe skin and hair problems, leading to death.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

TGF-β2 plays a key role in human hair growth and development.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

New genetic factors linked to acne risk were discovered, highlighting the role of certain pathways and genes.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Microvascular damage and platelet issues persist in ulcerative colitis remission, helping assess disease states.

The guideline provides recommendations for managing alopecia areata effectively.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.